United Imaging Healthcare – Manufacturer of High Quality Medical Equipment

Medical imaging plays a key role in the diagnosis, monitoring and treatment of many medical conditions. The quality of imaging equipment has a direct impact on the accuracy of diagnoses and the comfort of patients during examinations. That is why it is worth taking a closer look at United Imaging Healthcare (UIH), a company that provides state-of-the-art technology in molecular imaging, magnetic resonance imaging, computed tomography and digital radiography.

United Imaging Healthcare – meet the manufacturer of high quality medical imaging equipment

United Imaging Healthcare (UIH) is a multinational company committed to developing innovative solutions in the field of medical diagnostic imaging. Headquartered in Shanghai, the company has a global sales network with subsidiaries in the United States, India and Poland.

United Imaging Healthcare develops its position in the medical market by working closely with scientists, doctors, engineers and specialists from different regions of the world. Through this collaboration, the company provides the highest quality medical equipment and advanced software, and introduces many innovative solutions aimed at improving the quality of life for patients around the world.

Molecular imaging – PET/CT and PET/MR

UIH offers advanced molecular imaging systems, including those that combine positron emission tomography (PET) with computed tomography (CT) or magnetic resonance (MR). These PET/CT and PET/MR technologies are used in fields such as oncology, neurology and cardiology to accurately assess metabolic, hypoxic and molecular changes in tissues.

UIH’s equipment is characterised by extremely high sensitivity and the ability to detect even the faintest signals, allowing pathological changes to be identified in the early stages of disease. In addition, UIH molecular imaging systems are ergonomically designed and feature advanced automation and image analysis tools, making them a complete solution.

UIH Magnetic Resonance Imaging – image quality, performance and patient comfort

United Imaging Healthcare also provides Magnetic Resonance Imaging (MRI) systems that deliver outstanding image quality, performance and patient comfort. UIH focuses on the development of MRI systems with different magnetic field strengths, expanding the range of diagnostic options.

The technologies used in UIH’s MRI systems reduce examination time while improving patient comfort thanks to a wide bore and noise reduction during the procedure. In addition, these systems enable faster and more accurate diagnosis using advanced algorithms and artificial intelligence technologies to support image analysis.

UIH systems raise the bar in computed tomography

UIH offers a wide range of computed tomography (CT) equipment that combines the latest technology with excellent image quality. UIH CT scanners stand out in several ways:

  1. Minimised radiation dose to the patient.
  2. Automation of the examination process.
  3. Ability to acquire 4D data.
  4. Exceptional accuracy in oncology and cardiac diagnostics.

As a result, UIH computed tomography systems set new standards in the field of medical diagnostics.

Digital radiography – UIH introduces next generation digital radiography systems

UIH offers state-of-the-art digital radiography systems that use advanced image processing and radiation filtration technologies. As a result, UIH equipment offers excellent image quality and the ability to minimise radiation exposure to patients.

UIH offers a wide range of digital radiography solutions, including fixed and mobile DR systems as well as those designed for panoramic radiography.

Advanced molecular imaging, magnetic resonance, computed tomography and digital radiography technologies from market leader United Imaging Healthcare are breaking new ground in medicine and helping to improve the quality of patient care around the world.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”